nitrite. The presence of nitrite is used as a growth indicator that can be visually detected by a colour change after adding chemical reagents that are usually available in any TB laboratory for the routine identification of M. tuberculosis isolates.
The purpose of this study was to evaluate the NRA for the rapid detection of resistance to isoniazid (INH), streptomycin (SM), ethambutol (EMB) and rifampicin (RMP) and to compare the NRA with PM on solid medium and the automatic commercial system BACTEC MGIT960 under routine conditions.
One hundred and six M. tuberculosis clinical isolates obtained from patients of the University Hospital Clementino Fraga Filho, Institute of Chest Diseases of Federal University of Rio de Janeiro (UFRJ) from June 2003-December 2005 and the reference strain H37Rv (ATCC 27294), used as a control, were tested. All of the isolates and the control strain were maintained in Middlebrook 7H9 culture medium at -20ºC until they were tested. The antibiotics were obtained in pure powder form from Sigma Chemical Co (St Louis, MO, USA). The antibiotic stock solutions were prepared at 10 mg/mL by dissolving SM, INH and EMB in sterile distilled water and RMP in methanol. The stock solutions were stored at -20°C until used.
The PM was performed as previously described. The test was conducted on Lowenstein-Jensen (LJ) medium at the recommended critical concentrations of 4.0 µg/ mL for SM, 0.2 µg/mL for INH, 40.0 µg/mL for RMP and 2.0 µg/mL for EMB.
For the DST using the M960 system, the drugs from the BACTEC MGIT960 SIRE kit were used following the standard procedure (Siddiqi & Rüsch-Gerdes 2006) . The final drug concentrations were 1.0 µg/mL for SM, 0.1 µg/mL for INH, 1.0 µg/mL for RMP and 5.0 µg/mL for EMB.
The NRA was performed as described by Angeby et al. (2002) . Briefly, the antibiotic was included in the LJ medium at the recommended critical concentration for ) was also added. A part of the inoculum, adjusted to have turbidity equal to the turbidity of a tube of 1 McFarland standard, was diluted 1:10 in distilled water. For each isolate, 0.2 mL of the undiluted inoculum was added into the tubes containing the LJ medium with KNO 3 and the anti-TB drugs and 0.2 mL of the 1:10 dilution was inoculated into each of three tubes of drug-free media containing KNO 3 , serving as a triplicated growth control. The tubes were incubated at 37ºC for 14 days and 0.5 mL of a mixture of three reagents -the nitrate reductase developer (1 part 50% concentrated hydrochloric acid, 2 parts 0.2% sulfanilamide and 2 parts 0.1% N-1-naphthylenthylenediamine dihydrochloride) -was added to one drug-free control tube after seven days of incubation. If a colour change was observed in the control, the developer was also added to the remaining tubes. If there was no colour change in the control tube, the tubes were returned to the incubator and the procedure was repeated on the 10th day and, if necessary, on the 14th day. A strain was considered resistant if any colour change was observed in the drug-containing tube. The ethical clearance of this study was granted by the University Hospital Clementino Fraga Filho.
The contribution of TB laboratories to the global management of multidrug-resistant (MDR) TB is important for the rapid determination of drug susceptibility. Numerous alternative methods have been proposed for the detection of TB drug resistance. In this paper, the NRA was used as an alternative indirect method for the rapid detection of resistance to first-line antituberculous drugs in 106 M. tuberculosis clinical isolates with a high percentage of resistant strains (32 resistant to SM, 56 resistant to INH, 39 resistant to RMP and 21 resistant to EMB, with only 44 fully-sensitive isolates). An overall agreement of 95% was found between the NRA and PM methods (395 of 416 tests). The overall agreement between the NRA and M960 was 94% (361 of 382 tests) ( Table I) . The sensitivity, defined as the ability to detect true resistance, specificity, defined as the ability to detect true susceptibility, and the accuracy are shown in Table II . The accuracy of the NRA for both of the standard methods, PM and M960, for RMP (99% and 100%, respectively) was very good according to the criteria established by the World Health Organisation/International Union Against Tuberculosis and Lung Disease/Supranational Labora-/Supranational Laboratory Network, which has proposed accuracy levels of > 99% for RMP (Laszlo et al. 2002) . For the other drugs, only the test with EMB achieved the recommended accuracy of > 92%. For INH, five false-negative results were obtained with the NRA compared to the PM and six false-negative results compared to the MGIT. The accuracies obtained of 94.3% and 93.7% comparing the NRA with the PM and MGIT, respectively, did not match the accuracy of > 97% recommended for INH. According to Martin et al. (2008) , who conducted the review and meta-analysis of the NRA, the sensitivity obtained in this study was slightly below the recommended level (92%), but the specificity reached the specificity recommended by these authors (95%) for comparisons of the NRA with the PM and MGIT standard DST tests (Table II) . Also, the accuracy of the NRA test for SM was below the recommended level (92%) when the test was compared with the PM and MGIT, respectively 90% and 90.6%, but SM is recognised as a difficult drug to test even using the standard methods (Lazlo et al. 2002) . (Vareldzis et al. 1994 ) and can thus serve as a marker of MDR M. tuberculosis strains if resources are limited. The biggest advantage of the NRA is that it is performed in the classic LJ medium that TB laboratories use routinely for the diagnosis of TB, which makes this method easily implemented in routine laboratories. No expensive equipment is required to perform the NRA, facilitating its widespread application. A limitation of the NRA is that this method cannot be used for nitrate reductase-negative M. tuberculosis samples, but nitrate reductase-negative strains of M. tuberculosis are uncommon.
In conclusion, the NRA constitutes a useful tool for the detection of TB drug resistance in low-resource countries with limited laboratory facilities due to its low cost, ease of performance and lack of requirement for sophisticated equipment.
